Product Information
LIDOCAINE HCL 1% VIAL is a generic product labeled by Lifestar Pharma LLC, priced at $0.0700 per ML under NDC 70756064625. Its NADAC has been published 135 times since Mar 6, 2024.
FDA first approved this application on Jul 11, 2023. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/mL
Manufacturer
Lifestar Pharma LLCNDC
70756064625
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INFILTRATION; PERINEURAL
Effective Date
9/23/2026
Active Ingredients
LIDOCAINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA217693FDA Approved
7/11/2023
TE Code
AP
On Market Since
9/14/2023
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE HCL 1% VIAL has been published 135 times since Mar 6, 2024, and over the history we have for it it has declined 17.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0700 per ML |
|---|---|
| All-time high | $0.0853 (Apr 10, 2024) |
| All-time low | $0.0681 (Jul 22, 2026) |
| 52-week high | $0.0769 |
| 52-week low | $0.0681 |
| Median price | $0.0726 |
| Average price | $0.0732 |
| Largest weekly change | -11.2% (Apr 17, 2024) |
| Weeks tracked | 135 |
| Tracking since | Mar 6, 2024 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Lifestar Pharma LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lidocaine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAINE HCL 1% VIAL?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE HCL 1% VIAL, manufactured by Lifestar Pharma LLC, is $0.0700 per ML (NDC 70756064625), effective Sep 30, 2026.
How has the price of LIDOCAINE HCL 1% VIAL changed over time?
Over the history we have for it, the NADAC for LIDOCAINE HCL 1% VIAL has declined 17.9%. It has been tracked across 135 weekly CMS publications since Mar 6, 2024.
What are the highest and lowest recorded NADAC prices for LIDOCAINE HCL 1% VIAL?
Since Mar 6, 2024, the NADAC for LIDOCAINE HCL 1% VIAL has ranged from a low of $0.0681 (Jul 22, 2026) to a high of $0.0853 (Apr 10, 2024), with a median of $0.0726 per ML.
Are there cheaper alternatives to LIDOCAINE HCL 1% VIAL?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIDOCAINE HCL 1% 300 MG/30 ML, is $0.0681 per ML — about 3% below LIDOCAINE HCL 1% VIAL.
Who manufactures LIDOCAINE HCL 1% VIAL?
LIDOCAINE HCL 1% VIAL (NDC 70756064625) is labeled by Lifestar Pharma LLC, and CMS classifies it as a generic product.